We provide you with 20 years of free, institutional-grade data for TNXP stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of TNXP. Explore the full financial landscape of TNXP stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| LEDERMAN SETH | Open Market Purchase | 20,000 | $1.71 | 2022-07-01 | |
| LEDERMAN SETH | Open Market Purchase | 100,000 | $0.24 | 2022-03-28 | |
| LEDERMAN SETH | Open Market Purchase | 12,000 | $0.61 | 2021-09-28 | |
| Goodman Daniel Wintner | Open Market Purchase | 5,000 | $1.12 | 2021-05-26 | |
| LEDERMAN SETH | Open Market Purchase | 16,733 | $1.32 | 2021-03-25 | |
| SULLIVAN GREGORY M | Grant, award...etc | 41,322 | $0.51 | 2021-02-25 | |
| LEDERMAN SETH | Open Market Purchase | 35,000 | $0.68 | 2021-01-04 | |
| Treco James | Open Market Purchase | 5,500 | $0.89 | 2020-09-01 | |
| Bell Margaret Smith | Open Market Purchase | 5,391 | $0.93 | 2020-08-24 | |
| SULLIVAN GREGORY M | Open Market Purchase | 20,000 | $1.03 | 2020-08-19 | |
| Treco James | Open Market Purchase | 4,500 | $1.06 | 2020-08-17 | |
| OLUKOTUN ADEOYE Y | Open Market Purchase | 5,350 | $0.94 | 2020-08-17 | |
| LEDERMAN SETH | Open Market Purchase | 60,000 | $0.91 | 2020-08-17 | |
| BAGGER RICHARD H | Open Market Purchase | 10,000 | $0.91 | 2020-08-17 | |
| LEDERMAN SETH | Open Market Purchase | 20,000 | $1.16 | 2019-12-04 | |
| LEDERMAN SETH | Open Market Purchase | 5,000 | $2.49 | 2019-04-01 | |
| LEDERMAN SETH | Open Market Purchase | 25,000 | $2.38 | 2019-03-28 | |
| MORRIS JESSICA EDGAR | Grant, award...etc | 10,340 | 2019-02-27 | ||
| LEDERMAN SETH | Open Market Purchase | 500 | $4.64 | 2018-07-02 | |
| LEDERMAN SETH | Open Market Purchase | 500 | $4.58 | 2018-06-29 | |
| LEDERMAN SETH | Open Market Purchase | 500 | $4.55 | 2018-06-28 | |
| MARIO ERNEST | Open Market Purchase | 16,500 | $4.48 | 2018-06-27 | |
| SULLIVAN GREGORY M | Open Market Purchase | 10,000 | $3.96 | 2018-06-15 | |
| SAENGER BRADLEY | Open Market Purchase | 300 | $4.1 | 2018-06-14 | |
| MORRIS JESSICA EDGAR | Open Market Purchase | 300 | $4.19 | 2018-06-14 | |
| LEDERMAN SETH | Open Market Purchase | 2,000 | $4.37 | 2018-06-14 | |
| LEDERMAN SETH | Open Market Purchase | 1,000 | $4.37 | 2018-06-14 | |
| Rhodes John B | Open Market Purchase | 7,500 | $3.33 | 2018-06-06 |
The information provided in this report about TNXP stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Tonix Pharmaceuticals(NASDAQ:TNXP) 
Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, discovers, acquires, develops, and licenses small molecules and biologics to treat and prevent human diseases and alleviate suffering. Its immunology product candidates include vaccines to prevent infectious diseases an...
Website: http://www.tonixpharma.com
Founded: 2007
IPO Price: $4.25 (Aug 09, 2013)
Full Time Employees: 16
Sector: Healthcare
Industry: Biotechnology